Infanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer Injektionssuspension - Swissmedic Key 00619003 Registration Holder GlaxoSmithKline AG Name Infanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer Injektionssuspension Date of registration 29.09.1998 Introduction of Sequence 29.09.1998 ATC-Classification Diphtheria-Haemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus (J07CA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.08. Show package size Index Therapeuticus (Swissmedic) 08.08. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 34.32 Limitation Yes Limitation text
Deductible 10 % Consumer price 53.75 Feedback FB GTIN 7680006190030 Medication Code Impfstoffe Pharmacode Disponibility
Composition I) DTPa-IPV: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U., aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, polysorbatum 80, formaldehydum.
II) Hib: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, pro praeparatione.
I) et II) corresp. DTPa-IPV + Hib: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U., polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, polysorbatum 80, formaldehydum. Packungsbestandteile Label II
Galenic Form Injection suspension Excipiens BAG: Active Agent Dose Haemagglutinium Filamentosum (B. Pertussis) 25 mcg Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg Pertactinum (B. Pertussis) 8 mcg Toxoidum Diphtheriae Toxoidum Pertussis 25 mcg Toxoidum Tetani Virus Poliomyelitis Typus 1 Inactivatum (Mahoney) 40 UI Virus Poliomyelitis Typus 2 Inactivatum (Mef1) 8 UI Virus Poliomyelitis Typus 3 Inactivatum (Saukett) 32 UI
Inactive agents Dose Conjugata cum Toxoido Tetani 10 µg Lactosum Polysaccharida Haemophili Influenzae Typus B 20752
correspond I) et II) corresp. DTPa-IPV + Hib: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U., polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, aluminium ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum, lactosum, medium 199, residui: polysorbatum 80 et formaldehydum et neomycini sulfas et polymyxini B sulfas, aqua q.s. ad suspensionem pro 0.5 ml BAG: Active Agent Dose Haemagglutinium Filamentosum (B. Pertussis) 25 mcg Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg Pertactinum (B. Pertussis) 8 mcg Toxoidum Diphtheriae Toxoidum Pertussis 25 mcg Toxoidum Tetani Virus Poliomyelitis Typus 1 Inactivatum (Mahoney) 40 UI Virus Poliomyelitis Typus 2 Inactivatum (Mef1) 8 UI Virus Poliomyelitis Typus 3 Inactivatum (Saukett) 32 UI
Label I
Galenic Form Pulver und Suspension zur Herstellung einer Injektionssuspension Excipiens Active Agent Dose Haemagglutininum Filamentosum (B. Pertussis) 25µg / 0.5ml Pertactinum (B. Pertussis) 8µg / 0.5ml Toxoidum Diphtheriae 30U.I. / 0.5ml Toxoidum Pertussis 25µg / 0.5ml Toxoidum Tetani 40U.I. / 0.5ml Virus Poliomyelitis Typus 1 Inactivatus (Stamm Mahoney) 40U. / 0.5ml Virus Poliomyelitis Typus 2 Inactivatus (Stamm Mef-1) 8U. / 0.5ml Virus Poliomyelitis Typus 3 Inactivatus (Stamm Saukett) 32U. / 0.5ml
BAG: Active Agent Dose Haemagglutinium Filamentosum (B. Pertussis) 25 mcg Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg Pertactinum (B. Pertussis) 8 mcg Toxoidum Diphtheriae Toxoidum Pertussis 25 mcg Toxoidum Tetani Virus Poliomyelitis Typus 1 Inactivatum (Mahoney) 40 UI Virus Poliomyelitis Typus 2 Inactivatum (Mef1) 8 UI Virus Poliomyelitis Typus 3 Inactivatum (Saukett) 32 UI
Inactive agents Dose Alumine 0.5mg / 0.5ml Medium 199 Sodium Chloride Neomycin Sulfate Polymyxine b Sulfate
Source Data was imported : 05.01.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
